1. Galectin-3 Involvement in Fibrotic Diseases
    Xiaosong Jiang et al, 2020, Anti-fibrotic Drug Discovery CrossRef
  2. Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
    Ignacio M. Seropian et al, 2018, Mediators of Inflammation CrossRef
  3. Galectin-3 in Cardiovascular Diseases
    Valeria Blanda et al, 2020, International Journal of Molecular Sciences CrossRef
  4. Galectin‐3 exacerbates ox‐LDL‐mediated endothelial injury by inducing inflammation via integrin β1‐RhoA‐JNK signaling activation
    Xiumei Chen et al, 2019, Journal of Cellular Physiology CrossRef

  5. Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro


    Qingqing Yin et al, 2020, Journal of Inflammation Research CrossRef
  6. Galectin functions in cancer-associated inflammation and thrombosis
    Linus Kruk et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
  7. Pectin: Health-promoting properties as a natural galectin-3 inhibitor
    Lingzhuo An et al, 2024, Glycoconjugate Journal CrossRef
  8. Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme
    Willie Elliott Jr, 2024, American Journal of Cancer Research CrossRef
  9. Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3
    Suhail Al-Salam et al, 2022, International Journal of Molecular Sciences CrossRef
  10. Letter to the Editor: Not all modified citrus pectins are the same: size does matter
    Isaac Eliaz, 2019, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  11. Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study
    Abayomi Oyenuga et al, 2019, Angiology CrossRef
  12. The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease
    Adel Abo Mansour et al, 2022, Cardiovascular Diabetology CrossRef
  13. Unraveling the role of galectin-3 in cardiac pathology and physiology
    Ignacio M. Seropian et al, 2023, Frontiers in Physiology CrossRef
  14. Potential Roles of Modified Pectin Targeting Galectin-3 against Severe Acute Respiratory Syndrome Coronavirus-2
    Frederick Odun-Ayo et al, 2021, J CrossRef
  15. Citrus Pectin modulates Chicken Peripheral Blood Mononuclear Cell (PBMC) Proteome in vitro
    G. Ávila et al, 2024, Poultry Science CrossRef
  16. Value of Galectin-3 in Acute Myocardial Infarction
    Mingxing Li et al, 2020, American Journal of Cardiovascular Drugs CrossRef
  17. Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathway
    Hsiu‐Chung Ou et al, 2019, Environmental Toxicology CrossRef
  18. The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
    Grażyna Sygitowicz et al, 2021, Biomolecules CrossRef
  19. Cardioprotective effects of galectin-3 inhibition against ischemia/reperfusion injury
    Dan Mo et al, 2019, European Journal of Pharmacology CrossRef
  20. Locally delivered modified citrus pectin - a galectin-3 inhibitor shows expected anti-inflammatory and unexpected regeneration-promoting effects on repair of articular cartilage defect
    Yiyun Zhang et al, 2022, Biomaterials CrossRef
  21. Galectin-3 Is a Potential Mediator for Atherosclerosis
    Ziyu Gao et al, 2020, Journal of Immunology Research CrossRef
  22. Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin‐3‐NLRP3 Signaling Pathway
    Hongxia Li et al, 2021, Molecular Nutrition & Food Research CrossRef
  23. Recent progress and treatment strategy of pectin polysaccharide based tissue engineering scaffolds in cancer therapy, wound healing and cartilage regeneration
    Jijo Koshy et al, 2024, International Journal of Biological Macromolecules CrossRef
  24. Advances in Studies Using Vegetable Wastes to Obtain Pectic Substances: A Review
    Flávia Roberta Buss Marenda et al, 2019, Journal of Polymers and the Environment CrossRef
  25. In vitro fermentation properties of pectins and enzymatic-modified pectins obtained from different renewable bioresources
    Alvaro Ferreira-Lazarte et al, 2018, Carbohydrate Polymers CrossRef
  26. Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction
    Federico Ferro et al, 2024, Trends in Molecular Medicine CrossRef
  27. Anti-inflammation effects of highly purified low-Mw RG-I pectins on LPS-activated macrophages
    Dongmei Wu et al, 2021, Bioactive Carbohydrates and Dietary Fibre CrossRef
  28. New Classification of Macrophages in Plaques: a Revolution
    Hao Deng et al, 2020, Current Atherosclerosis Reports CrossRef
  29. Pleiotropic Effects of Modified Citrus Pectin
    Isaac Eliaz et al, 2019, Nutrients CrossRef